• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Pro-Files

Jonathan Bender’s off-court rebound

By
Andrew Lawrence
Andrew Lawrence
and
Tom Ziegler
Tom Ziegler
Down Arrow Button Icon
By
Andrew Lawrence
Andrew Lawrence
and
Tom Ziegler
Tom Ziegler
Down Arrow Button Icon
June 2, 2014, 8:00 AM ET
Jonathan Bender
Photo Editor: Neil Harris Assignment: © Robert SealePhotograph by Robert Seale

Fifteen years ago Jonathan Bender was basketball’s hottest product, a 6-foot-11, 202-pound action figure with an explosive perimeter game that no right-minded GM could afford to pass up. An early edition Durantula. Well, that was the hype, at least.

There was cause for it. In his first game as a pro in 2000, playing for the Indiana Pacers, Bender was as good as advertised, dropping 10 points — a high-water mark for a high schooler in his NBA debut. But there was one overlooked design flaw in the Pacers’ prized prospect: Bender had chronically bad knees. Halfway through his fourth season — and just months after signing a four-year, $28 million contract — he had arthroscopic surgery on his left knee to repair a degenerative condition. The procedure seemed only to make his joints worse. He played just 30 more games before limping out of the NBA in the ’06 season. At just 25 years old.

Bender, now 33, says he knew early on he couldn’t last and didn’t want to spend the balance of whatever playing career he had left confined to a rehab room. He preferred to be like Pacers owner Mel Simon, a strip-mall magnate who seemed to make money while he slept. Bender’s fascination with his boss ran so deep, in fact, that he often drove to Simon’s house uninvited in search of the secret to his success — as if it might be lying at the front gate next to the Indianapolis Star.

Throughout his NBA career, Bender had promoted concerts, started a record label, bought real estate — “tried everything big,” he says. Most of the ventures lost money.

Then one afternoon, while at a public park in Houston, he hit on an idea for a contraption that could improve the way people walked. “Literally in about five minutes, I had the whole thing put together, with duct tape and some cables and ankle weights from the corner pharmacy,” he says. His invention looked like a weightlifting belt with a pair of resistance bands (intended to strengthen the muscles around the lower joints) dangling from the bottom. “I tried the device on, and it worked exactly like I imagined. That’s when I told myself, ‘If I can create a product that helps me, I know it’ll help everyone else.’ ”

He spent two years testing a prototype on friends before taking it to researchers at Purdue University. Then Bender trained with it himself for a year. By the end, his knees were strong — strong enough for the NBA, even. Donnie Walsh, the Knicks’ GM and the same man who’d snatched him years before for the Pacers, was so impressed with Bender’s recovery he signed him midway through the 2009-10 season. His numbers on the court were solid, but his stats in the training room blew the Knicks doctors away; Bender had the most lower-body power on the team.

Walsh offered him a chance to return the next season, but Bender declined. “It just felt like I’d be going backward,” he says. Instead, he invested the time in finding a Chinese manufacturer and researching distribution channels. In July 2013, his creation — the JB Intensive Trainer — hit the market. He set a goal of doing $500,000 in sales in his rookie year, and quickly passed that on the strength of partnerships with Relax the Back and an affiliate network (think Mary Kay). Order fulfillment and customer service are handled by third parties. Bender won’t say whether his company is profitable, but says sales are growing 40% month-over-month.

The most satisfying part, he says, is not to feel like a product anymore. He’s something new and improved — his own brand.

WATCH: How basketball’s biggest prospect became a health businessman

This story is from the June 16, 2014 issue of Fortune.

About the Authors
By Andrew Lawrence
See full bioRight Arrow Button Icon
By Tom Ziegler
See full bioRight Arrow Button Icon

Latest in Management

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Most Popular

placeholder alt text
Law
Amazon is cutting checks to millions of customers as part of a $2.5 billion FTC settlement. Here's who qualifies and how to get paid
By Sydney LakeJanuary 6, 2026
2 days ago
placeholder alt text
Economy
Mark Cuban on the $38 trillion national debt and the absurdity of U.S. healthcare: we wouldn't pay for potato chips like this
By Nick LichtenbergJanuary 6, 2026
2 days ago
placeholder alt text
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top colleges
By Jake AngeloJanuary 6, 2026
2 days ago
placeholder alt text
Future of Work
AI layoffs are looking more and more like corporate fiction that's masking a darker reality, Oxford Economics suggests
By Nick LichtenbergJanuary 7, 2026
19 hours ago
placeholder alt text
Success
MacKenzie Scott sends millions to nonprofit that supports anti-Israel and pro-Muslim groups, two of which are facing federal probes
By Sydney LakeJanuary 6, 2026
2 days ago
placeholder alt text
Personal Finance
Janet Yellen warns the $38 trillion national debt is testing a red line economists have feared for decades
By Eva RoytburgJanuary 5, 2026
3 days ago
0